← All Ocean Biomedical, INC filings

Ocean Biomedical, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
OCEA
Ocean Biomedical, INC
10-K/A: Ocean Biomedical Files Amendment to Form 10-K to Include Omitted Information
Ocean Biomedical has filed an amendment to its annual report on Form 10-K to include information previously omitted regarding directors, executive officers, corporate governance, executive compensation, security ownership, related transactions, director independence, and principal accountant fees.
OTC.Pink
OCEA
Ocean Biomedical, INC
10-K: Ocean Biomedical Reports Annual Results, Highlights Pipeline Progress
Ocean Biomedical, Inc. files its annual report on Form 10-K, detailing its financial results for the year ended December 31, 2024, and providing an update on its preclinical development programs.
OTC.Pink
OCEA
Ocean Biomedical, INC
10-K: Ocean Biomedical Reports 2023 Financial Results, Outlines Pipeline Progress
Ocean Biomedical, a biopharmaceutical company, released its 2023 annual report, detailing its financial status and progress in developing its pipeline of therapeutic candidates.